Back to Results
First PageMeta Content
Cancer vaccine / Vaccination / Nottingham / Breast cancer / Personalized medicine / Melanoma / BioCity Nottingham / Signature BioScience / Medicine / Local government in England / Counties of England


Technology Transfer The Sir Colin Campbell Building The University of Nottingham Innovation Park, Triumph Road Nottingham, NG7 2TU UK
Add to Reading List

Document Date: 2014-01-30 07:16:23


Open Document

File Size: 694,91 KB

Share Result on Facebook

City

Shanghai / Boston / /

Company

Azotic Technologies Ltd / Molecular Profiles Limited / Crown Bioscience Inc / EventMAP (2003) Eminate Limited / Fusion IP plc / Enterprise Capital Fund / Flavometrix Ltd / Columbia Laboratories Inc. / ENCOS Ltd / PRECOS Ltd. / M4 Technologies Ltd / Company Portfolio M4 Technologies Ltd / Eminate Ltd / Pharminox Ltd / Company Portfolio Nottingham Prognostics Ltd / Gamma Technologies Ltd / Scancell Ltd / Aptia Solutions / Critical Pharmaceuticals Ltd / Evocell Ltd / FaHRAS Ltd / Monica Healthcare Ltd. / Promethean Particles Ltd / Nottingham Investment Fund / Urban Design Ltd / Oncimmune Ltd / Arana Therapeutics / Company Portfolio Aptia Solutions Ltd / Staff Roster Solutions Ltd / Nottingham Gynaecological Devices Limited / Family History Risk Assessment Software / The University / Platelet Solutions Ltd / /

Continent

Europe / /

Country

United Kingdom / China / United States / /

Currency

GBP / USD / /

/

Event

Company Expansion / M&A / Business Partnership / FDA Phase / Funding / Product Issues / /

Facility

Molecular Profiles Ltd Two University of Nottingham / SWiNG reactor / Nottingham City Hospital / The University of Nottingham’s School / University Architecture / University of Nottingham / The University of Nottingham / University of Oxford / Technology Transfer The Sir Colin Campbell Building The University of Nottingham Innovation Park / Queen’s Medical Centre / /

IndustryTerm

analytical and development solutions / software builds / niche expertise and technologies / expert consultancy / technology medicine / pharmaceutical industry / biotechnology industries / large multinational pharmaceutical / treatment of growth failure / large pharmaceutical / food flavour assessment / resource management / resolution imaging systems / sustainable energy research / art algorithms / technology transfer services / sustainable product / resource planning solutions / continuous hydrothermal synthesis technology / food / manufacturing process / energy / pharmaceutical development services / workforce management solutions / models and services / treatment of melanoma / multifunction device / electrophysiological systems / treatment of cancer / biotechnology businesses / manufacturing / acquired nitrogen fixation technology / pharmaceutical development / technology development research / biotechnology / medical devices / sustainable solution / biological drug products / pharmaceutical / nitrogen fixing bacteria / project management / long acting injectable products / biopharmaceutical / service incorporating cutting edge technology / food security / drug delivery technologies / natural nitrogen fixation technology / wearable device / using electrophysiological systems / /

MedicalCondition

strokes / HIV / chronic infectious diseases / skin cancer / melanoma / hepatitis / breast cancer / endometrio cancer / cancer / osteoporosis / spin-out Scancell Scancell’s first cancer / women-related cancers / tumours / common cancers / heart attacks / unique patient relevant and predictive cancer / prognostic breast cancer / breast cancers / tumour / lung cancer / /

MedicalTreatment

vaccination / surgery / gynaecological surgery / /

Organization

University of Nottingham’s School of Pharmacy / University’s Faculty of Engineering / University of Oxford / University of Nottingham Innovation Park / FDA / University’s School of Chemical and Environmental Engineering / £40m Enterprise Capital Fund / Nottingham University / University’s School of Electrical and Electronic Engineering / Nottingham City Hospital / Nottingham Technology Fund / University of Nottingham / Department of Obstetrics / Queen’s Medical Centre / /

Person

Nikin Patel / Martyn Davies / David Greenaway / Susan Huxtable / Philip Stone / Clive Roberts / Barrie Hayes-Gill / Peter Mansfield / Jonathan Lloyd Jones / Phil Williams / Frank C. Condella / Jr. / Professors Martyn Davies / Saul Tendler / Locate Therapeutics / Lindy Durrant / Bruce Venning / /

/

Position

CTO / Director / Intellectual Property Commercialisation Tel / CEO / Professor / Director of Intellectual Property Commercialisation / President and CEO / Commercial Manager / Technology Transfer Tel / Laparoscopic Assistant / Vice-Chancellor / leader / Chairman / specialist business unit / international leader in research / President & CFO / /

Product

Exam / Portal / M-16 / Event / Optime / Resource / SCIB1 / USA / sites / DNA vaccine / materials / /

ProvinceOrState

California / /

PublishedMedium

Magnetic Resonance Imaging / /

Technology

underpinning continuous hydrothermal synthesis technology / natural nitrogen fixation technology / apoptosis / drug discovery / Magnetic Resonance Imaging / drug-delivery / antibodies / biotechnology / acquired nitrogen fixation technology / art algorithms / MRI / drug delivery technologies / Environmental Engineering / regenerative medicine / /

URL

www.gammatechnologies.co.uk / www.eminate.co.uk / www.monicahealthcare.com / www.ngd.uk.com / www.prometheanparticles.co.uk / www.nottingham.ac.uk / www.plateletsolutions.co.uk / www.locatetherapeutics.com / www.nottinghamprognostics.com / www.pharminox.com / www.eventmap-uk.com / www.staffrostersolutions.com / www.criticalpharmaceuticals.com / www.flavometrix.co.uk / www.fahras.co.uk / www.azotictechnologies.com / www.encosltd.com / www.scancell.co.uk / www.aptiasolutions.com / www.oncimmune.com / www.evocell.co.uk / /

SocialTag